Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
Cited by 260
Related Papers
Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
|Cancer Cell|2013|320
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
|Cancer Informatics|2012|303
Iron-dependent histone 3 lysine 9 demethylation controls B cell proliferation and humoral immune responses
|Nature Communications|2019|224